Robert Wasserman
Stock Analyst at Benchmark
(2.10)
# 2,658
Out of 4,829 analysts
119
Total ratings
38.83%
Success rate
-7.27%
Average return
Main Sectors:
Stocks Rated by Robert Wasserman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Maintains: Buy | $95 → $75 | $52.84 | +41.94% | 6 | May 8, 2025 | |
| ITGR Integer Holdings | Maintains: Buy | $150 → $140 | $121.29 | +15.43% | 11 | Apr 25, 2025 | |
| XOMA XOMA Royalty | Initiates: Buy | $35 | $25.00 | +40.00% | 1 | Apr 17, 2025 | |
| IPA ImmunoPrecise Antibodies | Reiterates: Speculative Buy | $3 | $0.46 | +559.20% | 6 | Apr 1, 2025 | |
| KMDA Kamada | Initiates: Buy | $15 | $6.74 | +122.55% | 1 | Mar 21, 2025 | |
| OABI OmniAb | Maintains: Buy | $8 → $6 | $1.47 | +309.56% | 8 | Mar 20, 2025 | |
| ABCL AbCellera Biologics | Reiterates: Hold | n/a | $2.09 | - | 6 | Mar 3, 2025 | |
| HALO Halozyme Therapeutics | Reiterates: Buy | $75 | $65.87 | +13.86% | 8 | Feb 20, 2025 | |
| LGND Ligand Pharmaceuticals | Reiterates: Buy | $135 | $105.67 | +27.76% | 10 | Dec 23, 2024 | |
| BLFS BioLife Solutions | Reiterates: Buy | $30 | $24.20 | +23.99% | 6 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $8 | $0.97 | +723.30% | 6 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $2.08 | +140.38% | 3 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $12 | $5.88 | +104.08% | 17 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $2.58 | - | 7 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $129.00 | - | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $12 | $0.55 | +2,081.82% | 6 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $41.78 | +7.71% | 6 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $4 | $4.49 | -10.91% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $4 | $0.24 | +1,573.64% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $75 | $1.64 | +4,473.17% | 2 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $197.68 | - | 3 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $580 | $425.41 | +36.34% | 1 | Jul 16, 2021 |
Bio-Techne
May 8, 2025
Maintains: Buy
Price Target: $95 → $75
Current: $52.84
Upside: +41.94%
Integer Holdings
Apr 25, 2025
Maintains: Buy
Price Target: $150 → $140
Current: $121.29
Upside: +15.43%
XOMA Royalty
Apr 17, 2025
Initiates: Buy
Price Target: $35
Current: $25.00
Upside: +40.00%
ImmunoPrecise Antibodies
Apr 1, 2025
Reiterates: Speculative Buy
Price Target: $3
Current: $0.46
Upside: +559.20%
Kamada
Mar 21, 2025
Initiates: Buy
Price Target: $15
Current: $6.74
Upside: +122.55%
OmniAb
Mar 20, 2025
Maintains: Buy
Price Target: $8 → $6
Current: $1.47
Upside: +309.56%
AbCellera Biologics
Mar 3, 2025
Reiterates: Hold
Price Target: n/a
Current: $2.09
Upside: -
Halozyme Therapeutics
Feb 20, 2025
Reiterates: Buy
Price Target: $75
Current: $65.87
Upside: +13.86%
Ligand Pharmaceuticals
Dec 23, 2024
Reiterates: Buy
Price Target: $135
Current: $105.67
Upside: +27.76%
BioLife Solutions
Dec 19, 2024
Reiterates: Buy
Price Target: $30
Current: $24.20
Upside: +23.99%
Nov 19, 2024
Reiterates: Speculative Buy
Price Target: $8
Current: $0.97
Upside: +723.30%
Nov 12, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.08
Upside: +140.38%
Nov 7, 2024
Maintains: Buy
Price Target: $8 → $12
Current: $5.88
Upside: +104.08%
Nov 4, 2024
Reiterates: Hold
Price Target: n/a
Current: $2.58
Upside: -
Aug 5, 2024
Reiterates: Hold
Price Target: n/a
Current: $129.00
Upside: -
Jul 11, 2024
Reiterates: Speculative Buy
Price Target: $12
Current: $0.55
Upside: +2,081.82%
May 29, 2024
Reiterates: Buy
Price Target: $45
Current: $41.78
Upside: +7.71%
Mar 7, 2024
Reiterates: Speculative Buy
Price Target: $4
Current: $4.49
Upside: -10.91%
Mar 6, 2024
Reiterates: Speculative Buy
Price Target: $4
Current: $0.24
Upside: +1,573.64%
Apr 6, 2023
Reiterates: Speculative Buy
Price Target: $75
Current: $1.64
Upside: +4,473.17%
Oct 24, 2022
Downgrades: Hold
Price Target: n/a
Current: $197.68
Upside: -
Jul 16, 2021
Initiates: Buy
Price Target: $580
Current: $425.41
Upside: +36.34%